1. Case report of long term complete response in hepatocellular carcinoma to CARsgen's GPC3 CAR T cells (CT011) published in Frontiers in Immunology. News release. CARsgen Therapeutics Holdings Limited. August 18, 2022. https://www.carsgen.com/en/media/news/case-report-of-long-term-complete-response-in-hepatocellular-carcinoma-to-carsgen-s-gpc3-car-t-cells-ct011-published-in-frontiers-in-immunology/